2025 Degenerative Disc Disease Spine 
OrthoSpineNews
JUNE 18, 2025
BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , An overwhelming majority of my chronic low back pain patients either do not want or are not good candidates for invasive spine surgeries, yet they continue to feel debilitated, without many treatment options,” said Dr. Amirdelfan. Walnut Creek, Calif.; Jasper, Ga.;
OrthoSpineNews
APRIL 1, 2025
Our goal is to move spine surgery beyond the limits of legacy systems, reimagining treatment processes to make them safer, more efficient, and more effective for every patient. This seamless integration is intended to provide a personalized and effective approach to spine surgery, which enhances patient care and surgical efficiency.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OrthoSpineNews
JULY 10, 2025
OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron ® , a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) spine centers, with the first implantations expected in Q4 2025. spine centers. IDE clinical trial. To learn more, visit [link].
OrthoSpineNews
JUNE 25, 2025
June 25, 2025 /PRNewswire/ — VSI® proudly announces a groundbreaking achievement in spine surgery, led by nationally recognized spine surgeon Dr. Ehsan Jazini. ” Setting a New Standard in Spine Surgery First in the U.S. ” Setting a New Standard in Spine Surgery First in the U.S. RESTON, Va.,
OrthoSpineNews
MAY 13, 2025
May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. MELVILLE, N.Y.,
OrthoSpineNews
MARCH 3, 2025
Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. Pierce Nunley completes the first U.S. PerQdisc Surgery.
OrthoSpineNews
JULY 29, 2025
Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., We are pleased to announce the completion of enrollment in our ASCEND trial ahead of schedule, a key milestone in the continued development of VIA Disc NP,” said Barry Salzman, Co-President and Chief Operating Officer of Vivex.
Expert insights. Personalized for you.
Let's personalize your content